C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
about
Matrix metalloproteinases in exercise and obesityRole of C reactive protein (CRP) in leptin resistanceMatrix metalloproteinase 10 gene polymorphism and atherothrombotic cerebral infarction risk in a Han Chinese populationSystemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats,C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expressionCross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.Effect of wine phenolics on cytokine-induced C-reactive protein expression.Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κBGreater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults.Cardiotrophin-1 induces matrix metalloproteinase-1 in human aortic endothelial cellsPlasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications StudyThe connection between C-reactive protein and atherosclerosisIndividual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa.Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar ratsInflammation at the molecular interface of atherogenesis: an anthropological journeyMatrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study.Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.Biomarkers of inflammation and oxidative stress in atherosclerosis.C-reactive protein is a mediator of cardiovascular disease.Inflammatory and microenvironmental factors involved in breast cancer progression.Cocoa agronomy, quality, nutritional, and health aspects.Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression.Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease.Matrix metalloproteinases in cerebral ischemia.The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activityEffects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes.Adaptation of HepG2 cells to silver nanoparticles-induced stress is based on the pro-proliferative and anti-apoptotic changes in gene expression.proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.The relationship between osteopontin and adiponectin in patients with essential hypertension.Serum C-reactive protein level and prehypertension in two Asian populations.Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair.Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.C-reactive protein enhances macrophage lipoprotein lipase expression.Angiotensin II receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension.Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial.Periodontal inflammatory burden correlates with C-reactive protein serum level.MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
P2860
Q26741022-85F5D6B0-3127-48D7-8662-E2CC900BF9A4Q26865632-2C00068F-D6D2-4738-A1D4-B158B0D98EE8Q28689904-1BD50334-0B11-491C-AC5C-91D4D21958E5Q29249076-5652C9DB-3DE1-414A-AA3C-41F0BF501C3EQ33365792-DB6F624B-CB31-47C0-B247-6B7A391D41E2Q33428506-509ECC1F-9129-4446-A62D-73C6C01924E2Q33699620-EBFE05A7-8CFB-4A86-B6DA-C251C5B9EAE4Q34374198-469E5A32-9F46-419B-8638-1D862FC624D7Q34404221-1A669C67-E3FA-4B42-ADA3-465C2C0197E7Q34918559-7F787743-B2E7-45CD-880E-0AB410F2E19CQ35166512-B9E7C818-DD76-4352-A883-B9A978FB2331Q35999439-329E83A5-17FE-4855-9B36-C89C6DFAF01DQ36313986-3C8EA6FB-7169-4A4E-A8F4-40C9DFCCA9CDQ36558323-C9B04A5E-36B6-40FE-AE41-B4AB818027B1Q36943039-9747F2A0-55CD-4011-B977-5342DBA09228Q37023639-96B1F80B-760A-4697-A2E3-A23754CD9282Q37277958-EDFAC50D-8945-4BA0-B3FB-3E98CE82D3E1Q37414995-A9103841-3AAE-409C-AA58-1460DFF2B08EQ37443132-66064AB2-8439-413B-88A0-8D2583AD6FA3Q37765284-1FCEA321-2EE1-46BC-A44F-6834D511242EQ37777888-0F428C32-79A2-40C7-B762-C231C1F0F192Q38162168-54D0DF6C-2DC2-4A36-9760-0CBEE77B0830Q38219143-91B22195-F008-4101-BA13-9BB10EF7530FQ38447666-9B63D013-9ACF-41E9-8053-2F7F387243B0Q39117416-5DAA6B3C-559F-4E8F-9F2F-3C20E2F8286AQ40028510-8C1C5D44-0255-4A8A-8C56-9D81AA901D42Q40333177-0E372FA9-BFAD-4DB5-B7DC-B54D3954C980Q41782754-3AE1E012-ECD2-4C4E-AA5E-E35E903C7B5DQ42472923-365087CF-0D5F-4138-B146-6FD2206EBD17Q42710833-D038D70F-A6FD-49A8-8F1F-EB92B0B20526Q42844903-5EE25D8A-643E-44C8-89B2-27AA9343FC91Q43717775-686652CA-5D2D-4989-B9B9-33EE0063D66DQ45857193-80257A3C-1E0C-4B37-BA87-C5E101979EB1Q46068772-338818BA-123A-4727-B565-550C05C21C72Q46425647-3F236795-6CB9-45F2-A49F-55FB8E01A47DQ46758228-2BB5B7AB-8D39-4FFE-8F6F-9AC2102FA4C8Q47279917-E4AF0E01-412C-41AD-A701-B34556AEE42CQ51360578-8B257444-7735-420D-902B-0B53D20931D0Q53086675-13B3F5DB-5184-4632-8FEB-1988C8BBDEECQ55422210-660FC051-C115-4B5C-B381-A25BFCE563B7
P2860
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@en
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@nl
type
label
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@en
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@nl
prefLabel
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@en
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@nl
P2093
P50
P1476
C-reactive protein induces mat ...... d subclinical atherosclerosis.
@en
P2093
Ines Montero
Javier Díez
José I Monreal
Nerea Varo
Oscar Beloqui
P304
P356
10.1016/J.JACC.2005.10.070
P407
P577
2006-03-20T00:00:00Z